Clearance
Clearance — The volume of plasma from which a compound is completely removed per unit time, a key pharmacokinetic parameter for evaluating peptide elimination rates.
What Is Clearance?
Clearance (CL) is the volume of plasma completely cleared of a peptide per unit time (mL/min or L/hr). It is the primary pharmacokinetic parameter determining how quickly a peptide is removed from the body. Clearance, together with volume of distribution, determines the elimination half-life of a peptide (t1/2 = 0.693 x Vd / CL).
Clearance Mechanisms for Peptides
- Enzymatic proteolysis: Plasma and tissue proteases (endopeptidases, exopeptidases) degrade peptides to inactive fragments
- Renal filtration: Peptides < 60 kDa freely filter through glomeruli. Major clearance route for small peptides
- Hepatic uptake: Receptor-mediated endocytosis and intracellular degradation
- Target-mediated disposition: Binding to high-density receptors removes peptide from circulation
Reducing Clearance
PEGylation reduces renal filtration and protease access. Lipidation (albumin binding) protects from filtration. D-amino acid substitution and cyclization reduce proteolytic clearance. Fc fusion adds 21-day half-life from FcRn recycling.
Frequently Asked Questions
What is Clearance?
The volume of plasma from which a compound is completely removed per unit time, a key pharmacokinetic parameter for evaluating peptide elimination rates.
Why is Clearance important in peptide research?
Clearance is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.